FAM171A1 and breast carcinoma: Kaplan–Meier survival curve analyses of breast cancer patients by the PrognoScan, the Survival Express, and the KM plotter revealed an increased expression of FAM171A1, and that its levels correlate well with an overall poor survival of the breast cancer patients (Fig. 1e and Supplementary Fig. 1C).